These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9597164)

  • 1. Glutathione-dependent bioactivation of haloalkenes.
    Anders MW; Dekant W
    Annu Rev Pharmacol Toxicol; 1998; 38():501-37. PubMed ID: 9597164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific carcinogenicity of haloalkenes mediated by glutathione conjugation.
    Dekant W; Henschler D
    J Cancer Res Clin Oncol; 1999; 125(3-4):174-81. PubMed ID: 10235471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase.
    Dekant W; Vamvakas S; Anders MW
    Drug Metab Rev; 1989; 20(1):43-83. PubMed ID: 2653763
    [No Abstract]   [Full Text] [Related]  

  • 4. A mechanism of haloalkene-induced renal carcinogenesis.
    Dekant W; Vamvakas S; Koob M; Köchling A; Kanhai W; Müller D; Henschler D
    Environ Health Perspect; 1990 Aug; 88():107-10. PubMed ID: 2272303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of toxic glutathione conjugates from halogenated alkenes.
    Dekant W
    Toxicol Lett; 2003 Sep; 144(1):49-54. PubMed ID: 12919723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites.
    Anders MW; Lash L; Dekant W; Elfarra AA; Dohn DR
    Crit Rev Toxicol; 1988; 18(4):311-41. PubMed ID: 3288445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes.
    Finkelstein MB; Dekant W; Anders MW
    Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes.
    Lock EA
    Crit Rev Toxicol; 1988; 19(1):23-42. PubMed ID: 3056657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
    Iyer RA; Anders MW
    Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable transfection of LLC-PK1 cells with human microsomal glutathione S-transferase gene increases haloalkene glutathione S-conjugate formation and cytotoxicity.
    Otieno MA; Anders MW
    Biochem Biophys Res Commun; 1997 May; 234(2):481-4. PubMed ID: 9177297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates.
    Commandeur JN; King LJ; Koymans L; Vermeulen NP
    Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial bioactivation of cysteine S-conjugates and 4-thiaalkanoates: implications for mitochondrial dysfunction and mitochondrial diseases.
    Anders MW
    Biochim Biophys Acta; 1995 May; 1271(1):51-7. PubMed ID: 7599225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process.
    Hinchman CA; Ballatori N
    J Toxicol Environ Health; 1994 Apr; 41(4):387-409. PubMed ID: 8145281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-dependent bioactivation of xenobiotics: implications for mutagenicity and carcinogenicity.
    Anders MW
    Princess Takamatsu Symp; 1990; 21():89-99. PubMed ID: 2134693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-dependent toxicity.
    Anders MW; Dekant W; Vamvakas S
    Xenobiotica; 1992; 22(9-10):1135-45. PubMed ID: 1441604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds.
    Anders MW
    Chem Res Toxicol; 2008 Jan; 21(1):145-59. PubMed ID: 17696489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine S-conjugates.
    Birner G; Bernauer U; Werner M; Dekant W
    Arch Toxicol; 1997; 72(1):1-8. PubMed ID: 9458184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereo- and regioselective conjugation of S-halovinyl mercapturic acid sulfoxides by glutathione S-transferases.
    Rosner E; Müller M; Dekant W
    Chem Res Toxicol; 1998 Jan; 11(1):12-8. PubMed ID: 9477221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-dependent bioactivation of haloalkanes and haloalkenes.
    Anders MW
    Drug Metab Rev; 2004 Oct; 36(3-4):583-94. PubMed ID: 15554237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine S-conjugate beta-lyases.
    Cooper AJ; Pinto JT
    Amino Acids; 2006 Feb; 30(1):1-15. PubMed ID: 16463021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.